InfraReDx to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference

BURLINGTON, Mass., Dec. 3, 2010 /PRNewswire/ — InfraReDx, Inc., a medical
device company developing intelligent cardiovascular diagnostic
imaging technologies, today announced that James E. Muller, M.D.,
founder and chief executive officer, will be presenting at the 5th
Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity
Conference, to be held December 7-8, 2010, at the Nikko Hotel in
San Francisco.

The InfraReDx presentation is scheduled to take place on
Tuesday, December 7 at 4:00 p.m. PST. A live audio webcast will be
available through the Media Center on the corporate website, www.infraredx.com. This
webcast will be archived following the live event.

About InfraReDx, Inc.InfraReDx, Inc. is a privately funded
medical device company improving patient care through the
development and commercialization of intelligent imaging
technologies to improve the diagnosis and treatment of coronary
artery disease. InfraReDx’s LipiScan™ IVUS Coronary Imaging
System is the first and only available catheter to combine both
near-infrared spectroscopy (NIR) and intravascular ultrasound
(IVUS) technologies to both visualize and characterize the
intracoronary lipid core plaques (LCP) suspected of causing the
majority of heart attacks. Founded in 1998, InfraReDx is
headquartered in Burlington, Massachusetts. For more information,
visit www.infraredx.com.
 Contacts:

Susan Heins (media)Pure Communications, Inc. 864-286-9597
sjheins@purecommunicationsinc.com Grant FrazierVice President
of MarketingInfraReDx, Inc.781-345-9632
gfrazier@infraredx.com

‘/>”/>

SOURCE